Oxidative stress-modulating drugs have preferential anticancer effects - involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration

Semin Cancer Biol. 2019 Oct:58:109-117. doi: 10.1016/j.semcancer.2018.08.010. Epub 2018 Aug 24.

Abstract

To achieve preferential effects against cancer cells but less damage to normal cells is one of the main challenges of cancer research. In this review, we explore the roles and relationships of oxidative stress-mediated apoptosis, DNA damage, ER stress, autophagy, metabolism, and migration of ROS-modulating anticancer drugs. Understanding preferential anticancer effects in more detail will improve chemotherapeutic approaches that are based on ROS-modulating drugs in cancer treatments.

Keywords: Anticancer drugs; Function; Oxidative stress; Preferential killing; Redox homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use*
  • Autophagy / drug effects*
  • Cell Movement / drug effects*
  • DNA Damage / drug effects*
  • Endoplasmic Reticulum Stress / drug effects*
  • Humans
  • Oxidative Stress / drug effects*

Substances

  • Antineoplastic Agents